- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 455/00 - Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberineAlkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
Patent holdings for IPC class C07D 455/00
Total number of patents in this class: 21
10-year publication summary
|
1
|
2
|
0
|
1
|
1
|
0
|
0
|
1
|
0
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| ArQule, Inc. | 132 |
2 |
| Merck Sharp & Dohme LLC | 3735 |
2 |
| General Electric Company | 13888 |
1 |
| Merck Sharp & Dohme Corp. | 2183 |
1 |
| Allergan, Inc. | 2169 |
1 |
| Massachusetts Institute of Technology | 10239 |
1 |
| The Broad Institute, Inc. | 1975 |
1 |
| BTG International Limited | 37 |
1 |
| L'Universite Catholique de Louvain | 3 |
1 |
| Merck Canada Inc. | 77 |
1 |
| National University Corporation Chiba University | 502 |
1 |
| Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag | 17 |
1 |
| Teva Pharmaceuticals USA, Inc. | 639 |
1 |
| Universiti Sains Malaysia | 123 |
1 |
| University of Mississippi | 154 |
1 |
| The University of Queensland | 661 |
1 |
| Willow Biosciences Inc. | 21 |
1 |
| Gretals Australia Pty Ltd | 6 |
1 |
| Equinorm Ltd | 6 |
1 |
| Other owners | 0 |